Researchers Find Malignancy-Risk Gene Signature For Early-Stage Non-Small Cell Lung C

[News]

A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute...

More... (http://www.medicalnewstoday.com/releases/240047.php)